ReviewPatient related outcome measures2018

Impact of blinatumomab on patient outcomes in relapsed/refractory acute lymphoblastic leukemia: evidence to date.

Lindsey Hathaway et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.